Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/12/25 16:56 | 12/10/25 | ONC | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | V8 | O | SVP,GC | 6 | M.dm | 6,636 | 281.77 | 0 | 24 | 12 | 223 | D | ||||||||||||||
12/12/25 16:56 | 12/10/25 | ONC | Health | Drug | Pharmaceutical Preparations | Lee Chan Henry | V8 | O | SVP,GC | 6 | S.dm | -6,636 | 281.77 | 0 | -24 | 223 | D | |||||||||||||||
12/1/25 16:57 | 11/26/25 | ONC | Health | Drug | Pharmaceutical Preparations | Sanders Corazon (Corsee) D. | V8 | D | 2 | M.d | 1,313 | 249.96 | 0 | 5 | 10 | 57 | D | |||||||||||||||
12/1/25 16:57 | 11/26/25 | ONC | Health | Drug | Pharmaceutical Preparations | Sanders Corazon (Corsee) D. | V8 | D | 2 | S.d | -1,313 | 249.96 | 0 | -5 | 57 | D | ||||||||||||||||
11/19/25 16:57 | 11/17/25 | ONC | Health | Drug | Pharmaceutical Preparations | Wu Xiaobin | V8 | O | P,COO | 2 | S.m | -7,365 | 368.26 | 0 | -20 | 1,037 | D | |||||||||||||||
9/18/25 16:45 | 9/16/25 | ONC | Health | Drug | Pharmaceutical Preparations | Oyler John | V8 | DO | CEO | 1 | S | -9,056 | 325.71 | 0 | -28 | 0 | 53,506 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |